Ownership

13F as of Q2 2026 · 70.2M shares outstanding

Who owns EMMA?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Emmaus Life Sciences Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+20.6%

+9.81% a year

Each share's claim on the business

−17.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.54M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding EMMA.

Super Investors

Investment managers reporting EMMA on Form 13F

No 13F manager reports holding EMMA yet.

Institutional Funds

Mutual funds and ETFs reporting EMMA on Form N-PORT; together they hold 0.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AH Alger Health Sciences Fund Alger Funds	$561K	293.5K	0.42%	0.18%	July 31, 2020

Alger Health Sciences Fund

Alger Funds

Position value

$561K

% of company

0.42%

% of the fund

0.18%

As of

July 31, 2020

Comments